SCHEMBL4856637

SCHEMBL4856637

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3cccc(Br)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
MAPT P10636 3/20 0.45
ATM Q13315 2/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
ALPG P10696 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TLR9 Q9NR96 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.43
PTPN1 P18031 3/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
AR P10275 2/20 0.40
TNFRSF1A P19438 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853514 0.89 NR1H4 (0.47) BCHEACHEKDR
SCHEMBL4849921 0.89 BCHE (0.45) LMNAMAPTATMHTTALDH1A1
SCHEMBL4853736 0.89 BCHE (0.52) LMNAMAPTALDH1A1KDM4EBCHE
SCHEMBL4853345 0.89 RELA (0.48) PTPN1BCHEACHETNFRSF1ASYK
SCHEMBL4846169 0.88 BCHE (0.42) KDM4EPTPN1BCHEACHETNFRSF1A
SCHEMBL4845797 0.86 THRA (0.52) BCHEACHE
SCHEMBL4852888 0.85 HCRTR2 (0.42) LMNAMAPTATMHPGDHTT
SCHEMBL4846060 0.85 MAPT (0.50) LMNAMAPTATMHPGDHTT
SCHEMBL4846042 0.85 MAPT (0.50) LMNAMAPTATMHPGDHTT
SCHEMBL4852218 0.84 CAPN1 (0.50) LMNAMAPTPOLBTDP1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed